Web Hosting

“These are all reasonable questions to consider and evaluate in clinical trials. However, at this time, suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence,” FDA Commissioner Stephen Hahn and Dr. Peter Marks, head of the agency’s vaccine division, said in a statement Monday.

Source link